HCC Risk (AFP+PIVKA-II+ASAP formula)
This test measures AFP and PIVKA-II to screen for liver cancer, aiding in early detection and risk assessment, particularly for those with chronic hepatitis B or C.
- The description claims this is a screening tool and does not replace imaging or professional medical evaluation.
AI Readiness
Good foundation, but some important product data is still missing.
65%